feed,title,long_url,short_url
ðŸ’°Barrons,ResMed Stock Is S&P 500â€™s Worst Performer. GLP-1 Drugs Are a Risk.,https://barrons.com/articles/resmed-stock-sleep-apnea-glp-b82b22c1?mod=RTA,https://da.gd/qqdHm
